1. Introduction
===============

Post-operation nausea and vomiting ([@b1-epj-09-3508]) is observed in 20 to 70 percent of all operations ([@b2-epj-09-3508], [@b3-epj-09-3508]). These complications can open surgical stitches, increase the pressure inside the eye and skull, create water and electrolyte disorders and, even, lung aspiration ([@b4-epj-09-3508], [@b5-epj-09-3508]). Reviewing the literature reveals a frequency of 30% for nausea and vomiting after cataract operation ([@b6-epj-09-3508]). Despite relying on the introduction of new methods, operation and anesthesia is still abound with nausea and vomiting ([@b7-epj-09-3508]). Hypotension and the physical status of the patient play a major role in the occurrence of nausea and vomiting ([@b8-epj-09-3508]). Post-operative nausea and vomiting are one of the most common causes of dissatisfaction among patients after anesthesia ([@b9-epj-09-3508], [@b10-epj-09-3508]). Occurrence of nausea and vomiting after operation may result in dehydration, electrolyte disorders, high blood pressure, pulling of stitches, and ultimately, delayed discharge of outpatients ([@b11-epj-09-3508], [@b12-epj-09-3508]). Higher rates of post-operative nausea and vomiting are reported among the elderly and children. The type of operation (eye, ears, pharynx and nose, and thyroid) also directly impacts the frequency and occurrence of nausea ([@b13-epj-09-3508]). Cataract operations typically have a high risk of nausea and vomiting and the majority of patients are the elderly. Thus, it is necessary to use safe methods such as utilizing herbal medicines such as ginger, to control or reduce nausea and vomiting. Nausea and vomiting are controlled by anti-nausea medicines ([@b14-epj-09-3508]). Besides the medical methods to control nausea and vomiting, there are other popular non-medical relief methods ([@b15-epj-09-3508]). According to the statistics issued by WHO, nearly 80% of the world population use herbal medicines such as ginger for treatment. This figure is higher in underdeveloped countries and lower in developed countries ([@b16-epj-09-3508]). The root of ginger is used to treat nausea and vomiting ([@b17-epj-09-3508], [@b18-epj-09-3508]). Taking one gram of ginger powder is as effective as taking tranquilizing medicines to prevent nausea and vomiting after an operation ([@b19-epj-09-3508]). The Association of Herbal Medicine Products of the US has placed the ginger root at the highest level in terms of health and safety ranking. However, the appropriate amount must be prescribed with due care ([@b20-epj-09-3508]). Ginger rhizome is the root of the plant containing many active biological compounds such as Gingerols and Shogaols. These compounds have anti-nausea, anti-inflammatory, anti-cancer, and prostaglandins reducing effects ([@b21-epj-09-3508]). A review of the literature indicates that using ginger is completely safe and has no side-effects at all and it is as effective as taking anti-nausea medicines ([@b22-epj-09-3508]). Although there are many chemical anti-nausea medicines, they may cause different side effects for the patient. Thus, using herbal medicines such as ginger, especially for the elderly, is much more preferred and has no side effect ([@b23-epj-09-3508]). Considering the fact that those patients undergoing cataract operation are elderly, it is better to use safe herbal medicines such as ginger, rather than taking chemical anti-nausea and anti-vomiting medicines with their side effects. The present research was conducted in order to study and determine the influence of ginger on nausea and vomiting after cataract operation under general anesthesia.

2. Material and Methods
=======================

2.1. Trial design and participants
----------------------------------

This is an interventional research conducted according to the principles of double-blind placebo-controlled randomized clinical trial. The population included the patients who were candidates for cataract operations. This research was conducted in Towhid Hospital in Sanandaj, Iran which is under the supervision of Kurdistan University of Medical Sciences in 2015.

2.2. Inclusion and exclusion criteria
-------------------------------------

Some of the inclusion criteria were as follows: cataract surgery candidate, volunteering to participate in the research, having no background diseases (diabetes, chronic respiratory, renal, and liver diseases and cancer, dementia, Alzheimer's and other chronic or acute disorders), no previous nausea and vomiting, and using an (general) anesthetic method with specific medicines (Propofol, Sodium Thiopental) ([@b24-epj-09-3508]). Patient's withdrawal from the research and unpredicted events such as cardiac arrest or patient's death were the exclusion criteria.

2.3. Sample size and randomization
----------------------------------

Based on the statistical estimates with a 5% alpha and 20% beta and estimation of the average therapeutic difference of the two methods in the previous literature (20%), the sample was set for 33 people for each group. Considering the possibility of the patients' withdrawal from the study, 40 people were placed in each group and finally 122 patients applying for cataract operation were selected for the 3 groups. None of the samples got out of the research in this study. As of the sampling method, the patients were selected in the first stage purposefully based on inclusion criteria. In the second stage and in accordance with the random, the patients were allocated into three groups by drawing sealed envelopes from number one to three for each of the samples. Samples divided into three groups included the first intervention group (receiving ginger capsule in a single 1 gram dose the morning before the operation), the second intervention group (receiving ginger capsule in 2 separate 500 mg doses in the night and the morning before the operation) and the control (placebo) group. The first, second and third group finally had 40, 42 and 40 members respectively.

2.4. Intervention
-----------------

In the first intervention group, the patients were given a ginger capsule with a dose of 1 gram at 6 a.m. before the operation. As of the second group, they were given to 500 mg doses of ginger capsule at 10 p.m. and 6 a.m. before the operation. In the control group, they were given a placebo capsule similar to ginger at 6 a.m. before the operation. Ginger and placebo capsules with a specific dose of 1 gram were prepared with 500 mg ginger in each one. According to the literature, this dose of the medicine reduces the intensity and frequency of nausea and vomiting ([@b25-epj-09-3508], [@b26-epj-09-3508]). After randomly selecting one of the capsules numbered from 1 to 8 and giving it to the patient and registering the number, the patient would be supervised for 6 hours checking for the incidence and severity of nausea and incidence of vomiting. After the patient randomly selects the capsule and takes it, his demographic information will be registered in the information sheet with the number of his capsule.

2.5. Blinding
-------------

By measuring the frequency and intensity of nausea and vomiting on the day of the operation in relation with ginger and placebo capsules, the second researcher was double-blind. This method helped us eliminate the mental influences of the researcher and patient on the results.

2.6. Measuring outcomes
-----------------------

Information was used to record the frequency and intensity of the occurrence of nausea, vomiting and other demographic specifications. The intensity of nausea was scored from 0 to 10 based on the VAS. The expected consequence (intensity and frequency of nausea) on the patient in the recovery and operative unit of Towhid Hospital of Sanandaj was studied for 6 hours after the operation by the 2nd researcher. Although exclusion from research was something inevitable, there was an attempt to prevent the patients from being excluded based on the inclusion criteria.

2.7. Statistical methods
------------------------

The collected data were analyzed using SPSS version 20 software. We used Chi Square and Kruskal-Wallis test for the analyses of outcomes. The two-tail value of p \< 0.05 was considered as statistically significant. Also, before performing the statistical analyses, the normality of the variables' distribution was examined using the K-S test.

2.8. Research ethics
--------------------

Before beginning the research and after the confirmation of the plan by the Ethics Committee of Kurdistan University of Medical Sciences, the official consent of the ethics committee was obtained with the number IR.MUK.REC.93.132 on January 13, 2015. The enrollment of patients began on February 22, 2015, and the study continued until February 22, 2016. All the patients filled the Informed Consent form to take part in the study. The participants were informed about the objective and nature of the study, and each participant provided her written consent in her native language (Persian) prior to the study. Also, we were committed to keeping all of the participants' information confidential. For ethical considerations, if the patients were unwilling to take part in the research they were free to withdraw from the study at any time. Oral administration of ginger was safe and this matter was confirmed by the Ethics Committee of Kurdistan University of Medical Sciences.

3. Results
==========

The 122 patients requiring cataract operations had no statistically significant difference with one another in terms of their age. The average age of all three groups ranged from 66.9 to 72 years old (p\>0.05). There was also no statistical significant difference between the groups in terms of the gender and length of hospitalization among those three groups (p \>0.05). The results indicated a significant difference between the three groups based on the time of entering the recovery (p \<0.001) ([Table 1](#t1-epj-09-3508){ref-type="table"}), until 2 hours after operation (p \<0.02) and until 6 hours after the operation ([Table 1](#t1-epj-09-3508){ref-type="table"}). This difference was caused, due to less occurrence of nausea in the group taking ginger capsules in 2 separate doses each containing 500 mg ginger compared to the other 2 groups. The level of nausea occurrence right after entering the unit, exhibited no statistical difference among those three groups (p \<0.3) ([Table 1](#t1-epj-09-3508){ref-type="table"}). The intensity of nausea while entering the recovery, and 6 hours after recovery in all three groups, exhibited no significant difference, while a significant difference was observed between the three groups while entering the unit (p \< 0.02) and up to 2 hours after operation(p \< 0.02) in terms of the intensity of nausea. This difference was caused due to less intensity of nausea in the group taking ginger capsules in 2 separate doses each containing 500 mg ginger compared to the other 2 groups ([Table 2](#t2-epj-09-3508){ref-type="table"}). The frequency of the occurrence of vomiting while entering the recovery (p = 0.631) and 6 hours after operation (p \> 0.08) in all three groups, exhibited no significant difference. A significant difference was observed between the three groups while entering the unit (p \< 0.00) and up to 2 hours after operation (p \< 0.04) in terms of the frequency of vomiting. This difference was caused due to less frequency of vomiting in the group taking ginger capsules in 2 separate doses each containing 500 mg ginger, compared to the other 2 groups. In terms of occurrence of vomiting immediately after entering the unit, no statistically significant difference was observed between the 3 groups ([Table 3](#t3-epj-09-3508){ref-type="table"}).

4. Discussion
=============

As the results indicated, using ginger constantly and continuously in a certain dose could be effective in reducing the frequency and occurrence of nausea and vomiting. Although its effects were different in the hours following the cataract operation, the demand for using chemical medicines was reduced. In the present study, the frequency and occurrence of nausea and vomiting in the group taking ginger in two separate doses on the night and the day before the operation, was less than the group using one gram of ginger in the morning of the day of operation and also less than the groups taking placebo. This difference was significant. In previous studies, ginger, either orally ([@b22-epj-09-3508]) and in the form of an inhaler ([@b23-epj-09-3508]) has been effective on reducing the severity of nausea and vomiting after surgery ([@b23-epj-09-3508]) ([@b22-epj-09-3508]), chemotherapy ([@b24-epj-09-3508]) and pregnancy. In fact, adding ginger to antiemetic drugs had synergic effect on the efficacy of anti-nausea and vomiting. A Mandela et al. study found that adding ginger to antiemetic had synergic significant effect in the reduction of post-operative nausea ([@b25-epj-09-3508]). In a research titled "Investigating the influence of ginger and Metoclopramide in treating nausea and vomiting caused by pregnancy, Hematzadeh et al. found that the influence of ginger, on improving the intensity and frequency of nausea and vomiting, was significantly more than Metoclopramide and (contrary to Metoclopramide) ginger had no harms or side effects for the body of those taking it ([@b22-epj-09-3508]). Another study also pointed to the efficiency of using ginger for a long time and in high doses on the frequency and intensity of nausea. In an attempt to reduce nausea and vomiting after chemotherapy, Ebrahimi et al. used ginger root powder capsules about 1 gram a day in four doses (250 mg each) three days before and three days after chemotherapy combined with the standard anti-nausea diet and this diet could significantly reduce the frequency and intensity of nausea ([@b27-epj-09-3508]). Some texts have pointed to the fact that ginger has no effect on reducing the frequency and intensity of nausea ([@b20-epj-09-3508]). This might be due to using ginger for a short period of time ([@b20-epj-09-3508]). While the study by Dabaghzadeh et al. because ginger was given in doses of 500 mg in two divided doses, it could be effective in reducing nausea ([@b26-epj-09-3508]). In our research, ginger applied in a single dose on the morning before the operation had no influence on the intensity and frequency of nausea. While administration of ginger in two divided doses of 500 mg the night before and the morning of surgery leads to a reduction in the severity of nausea after surgery ([@b26-epj-09-3508], [@b27-epj-09-3508]). The results of the current research were in line with the previous studies conducted in this field and any gaps here were mostly caused by the time and doses of taking ginger. It means that ginger will be more effective if used regularly and in separate doses.

5. Conclusions
==============

As the results indicated, using ginger as a complement might reduce demand for anti-nausea chemical medicines. It could also reduce post-operative complications such as nausea and vomiting. However, some patients such as those undergoing cataract operations were elderly and using chemical medicines might have adverse effects on their health and body. Considering the effectiveness of ginger following a regular consumption pattern and in separate doses, it is recommended to use ginger in separate doses twice a day (500 mg each time) for a few days. It is recommended to conduct further studies before and after the operation about taking ginger in longer periods of time.
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###### 

Comparison the frequency of nausea occurrence among the three groups in various times (Pearson Chi-Square Test, df = 2)

  Number of Measurements              Group            Nausea   p-value                             
  ----------------------------------- ---------------- -------- --------- ------ ------ ----- ----- ------------
  In Recovery                         Intervention 1   4        10        36     90     40    100   p \< 0.001
  Intervention 2                      6                15.8     32        84.2   40     100         
  Control                             0                0        42        100    42     100         
  Entering The Unit                   Intervention 1   6        15        34     85     40    100   p \> 0.3
  Intervention 2                      5                13.2     33        86.8   40     100         
  Control                             0                0        42        100    42     100         
  Two Hours After Entering The Unit   Intervention 1   4        10        36     90     40    100   p \< 0.04
  Intervention 2                      3                7.5      37        86.5   40     100         
  Control                             0                0        42        100    42     100         
  6 Hours After Entering The Unit     Intervention 1   1        2.5       39     97.5   40    100   p \< 0.02
  Intervention 2                      5                13.2     33        86.8   40     100         
  Control                             1                2.4      41        97.6   42     100         
  Total                               122              100                                          

###### 

Comparison of nausea severity among the three groups in various times (Kruskal-Wallis test)

  Nausea                              Group            Mean    SD     p-value
  ----------------------------------- ---------------- ------- ------ ---------
  In Recovery                         Intervention 1   0.725   1.61   0.771
  Intervention 2                      0.590            1.39           
  Control                             0.62             1.47           
  Entering The Unit                   Intervention 1   0.35    1.00   0.038
  Intervention 2                      0.68             1.64           
  Control                             0.1              0.6            
  Two Hours After Entering The Unit   Intervention 1   0.25    0.63   0.028
  Intervention 2                      0.50             1.48           
  Control                             0.00             0.00           
  6 Hours After Entering The Unit     Intervention 1   0.15    0.48   0.101
  Intervention 2                      0.39             1.18           
  Control                             0.00             0.00           

###### 

Comparison the frequency of vomiting occurrence among the three groups in various times (using Pearson Chi-Square Test. df = 2)

  Number of Measurements              Group            Vomiting   p-value                             
  ----------------------------------- ---------------- ---------- --------- ------ ------ ----- ----- ------------
  In Recovery                         Intervention 1   2          5         38     95     40    100   p = 0.631
  Intervention 2                      2                5          38        95     40     100         
  Control                             4                9.5        38        90.5   42     100         
  Entering The Unit                   Intervention 1   0          0         40     100    40    100   p \< 0.005
  Intervention 2                      5                14.2       35        85.5   40     100         
  Control                             0                0          42        100    42     100         
  Two Hours After Entering The Unit   Intervention 1   0          0         40     100    40    100   p \< 0.04
  Intervention 2                      3                7.5        37        92.5   40     100         
  Control                             0                0          42        100    42     100         
  6 Hours After Entering The Unit     Intervention 1   1          2.5       39     97.5   40    100   p \> 0.08
  Intervention 2                      5                14.2       35        85.8   40     100         
  Control                             1                2.3        41        97.7   42     100         
  Total                               122              100                                            
